Hyperfine, Inc. (HYPR) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
3.86
↑+150% vs avg
5yr avg: 1.54
30Y Low0.5·High2.7
ROE
↓
-79.0%
↑-41% vs avg
5yr avg: -56.2%
30Y Low-79%·High-43%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
HYPR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Hyperfine, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $158M | $92M | $64M | $80M | $59M | $510M | — | — |
| Enterprise Value | $123M | $57M | $26M | $5M | $-59065680 | $321M | — | — |
| P/E Ratio → | -3.91 | — | — | — | — | — | — | — |
| P/S Ratio | 11.67 | 6.80 | 4.94 | 7.24 | 8.68 | 340.85 | — | — |
| P/B Ratio | 3.86 | 2.25 | 1.30 | 0.95 | 0.48 | 2.74 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
HYPR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.21 | 2.04 | 0.44 | -8.67 | 214.85 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
HYPR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Hyperfine, Inc. earns an operating margin of -273.4%. Operating margins have expanded from -436.1% to -273.4% over the past 3 years, signaling improving operational efficiency. A negative ROE of -79.0% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 49.8% | 49.8% | 45.7% | 43.1% | 13.3% | -78.0% | -162.2% | — |
| Operating Margin | -273.4% | -273.4% | -335.3% | -436.1% | -1084.2% | -4336.1% | -7990.1% | — |
| Net Profit Margin | -262.3% | -262.3% | -315.9% | -401.0% | -1073.7% | -4333.8% | -7944.6% | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -79.0% | -79.0% | -61.0% | -42.5% | -47.2% | -51.2% | -48.7% | -65.3% |
| ROA | -62.3% | -62.3% | -53.2% | -38.8% | -43.5% | -47.3% | -45.8% | -61.4% |
| ROIC | -316.4% | -316.4% | -307.8% | -485.0% | -3454.2% | -3950.5% | -498.0% | — |
| ROCE | -79.2% | -79.2% | -63.8% | -45.7% | -47.4% | -51.0% | -48.8% | -69.4% |
HYPR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $35M exceeds total debt of $0, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.01 | 0.00 | — | — | 0.00 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.86 | -0.76 | -0.89 | -0.96 | -1.01 | -0.93 | -0.92 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | — |
Net cash position: cash ($35M) exceeds total debt ($0)
HYPR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Hyperfine, Inc.'s current ratio of 4.34x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 3.73x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 10.14x to 4.34x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.34 | 4.34 | 6.15 | 10.14 | 14.62 | 12.55 | 16.60 | 15.63 |
| Quick Ratio | 3.73 | 3.73 | 5.48 | 9.39 | 14.09 | 12.28 | 16.18 | 15.63 |
| Cash Ratio | 2.99 | 2.99 | 4.31 | 8.57 | 13.43 | 11.98 | 15.23 | 14.78 |
| Asset Turnover | — | 0.25 | 0.22 | 0.12 | 0.05 | 0.01 | 0.00 | — |
| Inventory Turnover | 0.96 | 0.96 | 1.20 | 0.95 | 1.28 | 0.62 | 0.45 | — |
| Days Sales Outstanding | — | 175.52 | 235.17 | 136.68 | 167.66 | 157.13 | 216.02 | — |
HYPR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Hyperfine, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $94M | $72M | $71M | $70M | $70M | $25M | $5M |
Peer Comparison
Compare HYPR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 HYPRYou | $158M | -3.9 | — | — | 49.8% | -273.4% | -79.0% | -316.4% | — |
 PRCT | $1B | -14.8 | — | — | 63.7% | -33.7% | -24.9% | -55.7% | — |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 AEYE | $100M | -32.4 | — | — | 78.3% | -7.9% | -43.2% | -42.4% | — |
 GEHC | $28B | 13.5 | 10.0 | 18.5 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 IRTC | $4B | -89.8 | — | 118.8 | 70.6% | -4.9% | -36.6% | -5.2% | — |
 INSP | $1B | 9.3 | 19.1 | 16.7 | 85.4% | 5.6% | 19.8% | 6.0% | 0.5 |
 NVDA | $5.1T | 43.2 | 38.6 | 53.2 | 71.1% | 60.4% | 101.5% | 81.8% | 0.1 |
 MSFT | $3.1T | 30.9 | 19.7 | 43.7 | 68.8% | 45.6% | 33.3% | 24.9% | 0.7 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See HYPR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HYPR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HYPR vs PRCT
Side-by-side business, growth, and profitability comparison vs PROCEPT BioRobotics Corporation.
Start ComparisonHYPR — Frequently Asked Questions
Quick answers to the most common questions about buying HYPR stock.
What is Hyperfine, Inc.'s P/E ratio?
Hyperfine, Inc.'s current P/E ratio is -3.9x. This places it at the 50th percentile of its historical range.
What is Hyperfine, Inc.'s ROE?
Hyperfine, Inc.'s return on equity (ROE) is -79.0%. The historical average is -56.4%.
Is HYPR stock overvalued?
Based on historical data, Hyperfine, Inc. is trading at a P/E of -3.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Hyperfine, Inc.'s profit margins?
Hyperfine, Inc. has 49.8% gross margin and -273.4% operating margin.